Literature DB >> 23748029

AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth.

Ana Paula Cremasco Takano1, Gabriela Placoná Diniz, Maria Luiza Morais Barreto-Chaves.   

Abstract

Previous studies have indicated that AMP-activated protein kinase (AMPK) plays a critical role in the control of cardiac hypertrophy mediated by different stimuli such as thyroid hormone (TH). Although the classical effects of TH mediating cardiac hypertrophy occur by transcriptional mechanisms, recent studies have identified other responses to TH, which are more rapid and take place in seconds or minutes evidencing that TH rapidly modulates distinct signaling pathway, which might contribute to the regulation of cardiomyocyte growth. Here, we evaluated the rapid effects of TH on AMPK signaling pathway in cultured cardiomyocytes and determined the involvement of AMPK in T3-induced cardiomyocyte growth. We found for the first time that T3 rapidly activated AMPK signaling pathway. The use of small interfering RNA against AMPK resulted in increased cardiomyocyte hypertrophy while the pharmacological stimulation of AMPK attenuated this process, demonstrating that AMPK contributes to regulation of T3-induced cardiomyocyte growth.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AMPK; Cardiomyocyte hypertrophy; Thyroid hormone

Mesh:

Substances:

Year:  2013        PMID: 23748029     DOI: 10.1016/j.mce.2013.05.024

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

Review 1.  Role of thyroid hormones in ventricular remodeling.

Authors:  Viswanathan Rajagopalan; A Martin Gerdes
Journal:  Curr Heart Fail Rep       Date:  2015-04

2.  Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy.

Authors:  Gabriela P Diniz; Nathalia Senger; Marcela S Carneiro-Ramos; Robson A S Santos; Maria Luiza M Barreto-Chaves
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-12-28

3.  S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.

Authors:  Ana Paula Cremasco Takano; Carolina Demarchi Munhoz; Anselmo Sigari Moriscot; Sudhiranjan Gupta; Maria Luiza Morais Barreto-Chaves
Journal:  J Mol Med (Berl)       Date:  2017-02-04       Impact factor: 4.599

Review 4.  Cell maturation: Hallmarks, triggers, and manipulation.

Authors:  Juan R Alvarez-Dominguez; Douglas A Melton
Journal:  Cell       Date:  2022-01-06       Impact factor: 41.582

5.  An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies.

Authors:  Graziela S Ceravolo; Augusto C Montezano; Maria T Jordão; Eliana H Akamine; Tiago J Costa; Ana P Takano; Denise C Fernandes; Maria L Barreto-Chaves; Francisco R Laurindo; Rita C Tostes; Zuleica B Fortes; Renato P Chopard; Rhian M Touyz; Maria Helena C Carvalho
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

Review 6.  Repair Injured Heart by Regulating Cardiac Regenerative Signals.

Authors:  Wen-Feng Cai; Guan-Sheng Liu; Lei Wang; Christian Paul; Zhi-Li Wen; Yigang Wang
Journal:  Stem Cells Int       Date:  2016-10-09       Impact factor: 5.443

Review 7.  Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes.

Authors:  Jessica C Garbern; Richard T Lee
Journal:  Stem Cell Res Ther       Date:  2021-03-12       Impact factor: 6.832

8.  Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human Cardiomyocytes.

Authors:  Nils Bomer; Mario G Pavez-Giani; Frederik E Deiman; Annet N Linders; Martijn F Hoes; Christiane L J Baierl; Silke U Oberdorf-Maass; Rudolf A de Boer; Herman H W Silljé; Eugene Berezikov; Warner S Simonides; B Daan Westenbrink; Peter van der Meer
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

Review 9.  The Potential of Gamma Secretase as a Therapeutic Target for Cardiac Diseases.

Authors:  Sujoita Sen; Logan Hallee; Chi Keung Lam
Journal:  J Pers Med       Date:  2021-12-04

10.  YAP1 nuclear efflux and transcriptional reprograming follow membrane diminution upon VSV-G-induced cell fusion.

Authors:  Daniel Feliciano; Carolyn M Ott; Isabel Espinosa-Medina; Aubrey V Weigel; Lorena Benedetti; Kristin M Milano; Zhonghua Tang; Tzumin Lee; Harvey J Kliman; Seth M Guller; Jennifer Lippincott-Schwartz
Journal:  Nat Commun       Date:  2021-07-23       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.